Viral Hepatitis C - Victim of tainted blood scandal puts human face on criminal trial

Victim of tainted blood scandal puts human face on criminal trial
Philadelphia Inquirer - TORONTO - James Kreppner, his legal career halted when he contracted HIV and Hepatitis C through tainted blood, sat in the back of a courtroom Wednesday, putting a human face on a criminal trial resulting from Canada's worst public health scandal

Fonda Protest Missing -- Tour No Where in Sight
Sacramento Union - ane called President Nixon a warmonger for sending U.S. troops against the Vietnamese in their sanctuary of Cambodia. Nixon replied that Fonda and kind were a bunch of bums. At a Washington rally Fonda welcomed her fellow bums

Teen user hopes for escape from addiction
Bangor Daily News - Editor's Note: This week's column features a letter we received recently from a young inmate at the Mountain View Youth Development Center in Charleston, a state-run correctional facility for juvenile offenders. We found the letter so compelling and

Daily Planner: Monday
Chico Enterprise-Record - Chico Enterprise-Record Performances MIKELESS OPEN MIKE: 8 p.m., Has Beans, 501 Main St. Spoken word performances. Ongoing. Community BLOOD DRIVE: Donor hours 8 a.m.-1 p.m. Saturday; 8 a.m.-3 p.m. Monday and Wednesday; 11 a.m.-6 p.m. Tuesday and

Viral Hepatitis C - Robust Viral Load Reduction Successfully Achieved In Phase II Clinical Trial Of ANA380 In Lamivudine-Resistant,

Robust Viral Load Reduction Successfully Achieved In Phase II Clinical Trial Of ANA380 In Lamivudine-Resistant,
Medical News Today - Feb 15 12:03 PM
AnadysPharmaceuticals, Inc. (Nasdaq: ANDS) and L.G. Life Sciences, Ltd. announced principalfindings from an open label, multi-center, dose-escalation Phase II clinicaltrial, evaluating the safety and antiviral activity of ANA380 (LB80380) inpatients with lamivudine-resistant hepatitis B virus (HBV) infection... click link for more info.Save to My Web

West Coast Editor
BioWorld - Feb 15 9:02 PM
Anadys Pharmaceuticals Inc. and South Korean co-developer L.G. Life Sciences Ltd. reported strong data from a Phase II trial with ANA380 against chronic hepatitis B virus, a compound for which Novartis AG holds a license option.Save to My Web

Schering-Plough Reports FDA Grants Fast Track Designation to Oral HCV Protease Inhibitor SCH 503034
[Press Release] PR Newswire via Yahoo! Finance - Jan 30 6:18 AM
Schering-Plough today reported that the U.S. Food and Drug Administration has granted Fast Track designation to its investigational oral hepatitis C protease inhibitor , currently in Phase II clinical development for the treatment of chronic hepatitis C virus infection.Save to My Web

Ashok Leyland: On a roll
Business Standard India - Feb 10 10:32 AM
Ashok Leylands numbers for Q3 FY06 surprised the street mainly because the 22 per cent y-o-y top line growth comprised a value increase of around 20 per cent, on a volume growth of just 1.6 per cent y-o-y.Save to My Web

Chiron partners with Portland's AVI
San Francisco Business Times - Jan 30 10:23 AM
Chiron Corp. and AVI BioPharma Inc. made an agreement granting AVI a nonexclusive license to Chiron's patents and patent applications for the research, development and commercialization of drugs that fight the hepatitis C virus (HCV).Save to My Web

Viral Hepatitis C - 4-pronged attack in war on drugs

4-pronged attack in war on drugs
Ottawa Sun, Canada - Feb 9, 2006... An average of 300 people seek treatment outside the region each year. - Ottawa has a 21% rate of HIV and Hepatitis C infection among intravenous drug users. ...

Schering-Plough drug gets fast track
BusinessWeek - Jan 30, 2006... The drug, known as SCH 503034, is an oral therapy in mid-stage human studies testing it as a treatment for chronic hepatitis C infection. ...

Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in ...
RxPG NEWS, CA - Jan 18, 2006... in view of Tarvacin's promise as an important new treatment option for a number of viral infections, including chronic hepatitis C infection," said Steven W ...

Biomedical timeline
Knoxville News Sentinel (subscription), TN - Jan 19, 2006... permission. One tissue recipient claims she tested positive for syphilis after transplant; two claim hepatitis C infection. Dec. ...

New drug abuse team will tackle growing problem 'top to bottom'
Ottawa Citizen, Canada - Feb 10, 2006Ottawa's injection drug users have the highest hepatitis C infection rates in Canada, nine times higher than those in Toronto and the same as Vancouver's drug ...

Viral Hepatitis C - Jay Farrar rebuilds a no-frills Son Volt

Jay Farrar rebuilds a no-frills Son Volt
Fort Wayne News-Sentinel - Feb 15 2:13 PM
If you've seen Jay Farrar onstage - be it with alt-country favorite Uncle Tupelo, with the early version of Son Volt, or on his own - you know this is an artist not exactly prone to outbursts of laughter.Save to My Web

Nabi Biopharmaceuticals Announces U.S. Fast Track Designation for Civacir to Prevent Hepatitis C Re-Infection in Liver
RedNova - Feb 01 9:15 PM
ROCKVILLE, Md., Feb. 1 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals today announced important regulatory and clinical advancements for its product candidate Civacir(TM) [Hepatitis C Immune Globulin (Human)], an antibody for preventing Hepatitis C virus re-infection in liver transplants.Save to My Web

Most common hepatitis C virus grown in lab
Galveston County Daily News - Feb 06 10:22 PM
GALVESTON Researchers at the University of Texas Medical Branch at Galveston have successfully grown the most common and damaging form of the hepatitis C virus in human liver cell cultures.Save to My Web

GSK Announces Start Of Eltrombopag Phase III Worldwide Clinical Trial In Adults With Previously-Treated Idiopathic
Medical News Today - Feb 14 1:02 PM
GlaxoSmithKline plc (GSK) announced today the commencement of a worldwide clinical trial to investigate the safety and efficacy of eltrombopag (SB-497115-GR) as a once-daily orally-administered drug for adult patients with previously-treated idiopathic thrombocytopenic purpura (ITP). ITP is a disorder characterized by low platelet counts leaving patients at risk of episodes of spontaneous Save to My Web

Viral Hepatitis C - Tattooing Is a Major Route of Hepatitis C Infection, Says Researcher

Tattooing Is a Major Route of Hepatitis C Infection, Says Researcher
HIVandHepatitis.com: The Internet publication with accurate, timely and cutting-edge information on treatment and experimental vaccines for Hepatitis C.

MedlinePlus: Hepatitis C Infection Tied to Diabetes Risk
Hepatitis C Infection Tied to Diabetes Risk. ... Hepatitis C Infection Tied to Diabetes Risk. Printer-friendly version · E-mail this page to a friend ...

Hepatitis G
Seven of the 16 patients with HGV/HGBV-C infection had concurrent hepatitis C infection and one was infected with hepatitis B. Of the 519 hemodialysis ...

If You Have Hepatitis C Infection - Liver Health Information - The ...
If You Have Hepatitis C Infection. By ALF in collaboration with the Veterans Affairs Centers of Excellence in Research and Education for Hepatitis C ...

Viral Hepatitis C - ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis

ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis
... LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. 1975. Viral heaptitis, type B in experimental animals ...

http://202.154.204.240/content/cmri/edu/E_2_00.xls (MICROSOFT EXCEL)
... Does not Increase the Efficacy of Interferon in the Treatment of Mutant Type Chronic Viral Heaptitis B :-A Pilot Study ...

Untitled Document
... There are, however, non-viral heaptitis caused by drugs, alcoholic and toxi elements ...

Giornale di malattie infettive e parassitarie on Medscape - 20 12
... of Owren's Thrombotest in acute viral hepatitis, viral heaptitis of prolonged duration, acute post-hepatitis atrophy of ...

Viral Hepatitis C - Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program

Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program
[Press Release] PR Newswire via Yahoo! Finance - Jan 18 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical-stage product candidates for viral diseases and cancer, today announced that it has accelerated its clinical program for Tarvacin Anti-Viral for the treatment of chronic hepatitis C virus infection .Save to My Web

Viral Hepatitis C - ARROW THERAPEUTICS SELECTS HEP C CLINICAL CANDIDATE

ARROW THERAPEUTICS SELECTS HEP C CLINICAL CANDIDATE
Asia Pulse via Yahoo! Australia & NZ Finance - Feb 05 11:55 PM
Technology Save to My Web

Hepatitis, 'the silent killer,' driven out of the shadows
USA Today - Jan 22 6:43 PM
Until recent years, there was little the medical profession could do to help patients who had hepatitis B. That has changed. Today there are five medications for hepatitis B, including two approved in 2005.Save to My Web

Victim of tainted blood scandal puts human face on criminal trial
phillyburbs.com - Feb 08 3:10 PM
TORONTO - James Kreppner, his legal career halted when he contracted HIV and Hepatitis C through tainted blood, sat in the back of a courtroom Wednesday, putting a human face on a criminal trial resulting from Canada's worst public health scandal.Save to My Web

Proposal to give free pipes to crack addicts
The Scotsman: Health - Feb 08 5:15 PM
ADDICTS who smoke crack cocaine could be given free pipes at the taxpayers' expense to prevent the spread of tuberculosis and other diseases.Save to My Web

Savage Love
The Village Voice - Jan 24 11:02 AM
Q. My girlfriend of three years is a smoker. For a while her smoking didn't bother me. I come from a family of smokers, and I used to smoke. But now it's a huge turnoff. I've started a new job where I work with cancer patients and see the deadly . . . read more (By Dan Savage)Save to My Web